Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gemina Laboratories Ltd
(CSE:
GLAB
)
0.0300
UNCHANGED
Last Price
Updated: 9:30 AM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Gemina Laboratories Ltd
< Previous
1
2
Next >
Gemina Laboratories Announces Private Placement
November 13, 2024
Via
ACCESSWIRE
Gemina Laboratories Strategic Update
July 10, 2024
Via
ACCESSWIRE
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
June 20, 2024
Via
ACCESSWIRE
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Labs Announces Addition to its IP Portfolio
April 09, 2024
Via
ACCESSWIRE
Gemina Labs to Present at the Life Science Investor Forum June 20th
June 17, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Laboratories Sign First Strategic License Agreement
April 02, 2024
Via
ACCESSWIRE
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
March 21, 2024
Via
ACCESSWIRE
Gemina Announces Closing of $910,000 Convertible Note Financing
March 19, 2024
Via
ACCESSWIRE
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
June 15, 2023
Via
ACCESSWIRE
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Via
ACCESSWIRE
ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
October 10, 2023
Via
Get News
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
July 25, 2023
Via
ACCESSWIRE
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
June 05, 2023
Via
ACCESSWIRE
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
May 17, 2023
Via
ACCESSWIRE
Gemina Laboratories to Host Investor Webinar on March 30, 2023
March 27, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
March 07, 2023
Via
ACCESSWIRE
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
January 25, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
January 23, 2023
Via
ACCESSWIRE
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
January 10, 2023
Via
ACCESSWIRE
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
January 06, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Via
ACCESSWIRE
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Via
ACCESSWIRE
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 07, 2022
Via
ACCESSWIRE
Gemina Labs Enters into Licence and Manufacturing Agreements
October 06, 2022
Via
ACCESSWIRE
Gemina Labs Presents at the H.C. Wainwright Global Investment Conference
September 12, 2022
Via
ACCESSWIRE
Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer
September 06, 2022
Via
ACCESSWIRE
Gemina Labs Announces Closing Of Concurrent Private Placement
July 11, 2022
VANCOUVER, BC / ACCESSWIRE / July 11, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced non-brokered private...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
June 30, 2022
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has closed its previously announced...
From
Gemina Laboratories Ltd.
Via
AccessWire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
